Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acute Impact of IM Aripiprazole and Olanzapine on Insulin Resistance in High Risk Prediabetics

NCT01411930 is registered in ClinicalTrials.gov with Veterans Medical Research Foundation as lead sponsor.

NCT NCT01411930
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01411930 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acute Impact of IM Aripiprazole and Olanzapine on Insulin Resistance in High Risk Prediabetics
Lead sponsor
Veterans Medical Research Foundation
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2009
Completion date
August 31, 2011
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes